img

Global Glucagon Like Peptide 2 Receptor Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Glucagon Like Peptide 2 Receptor Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Glucagon Like Peptide 2 Receptor report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Glucagon Like Peptide 2 Receptor market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Short Bowel Syndrome and Diabetes are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Glucagon Like Peptide 2 Receptor industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Glucagon Like Peptide 2 Receptor key manufacturers include Hanmi Pharmaceuticals Co Ltd, Naia Ltd, Takeda, Tasly Pharmaceutical Group Co Ltd and Zealand Pharma AS, etc. Hanmi Pharmaceuticals Co Ltd, Naia Ltd, Takeda are top 3 players and held % sales share in total in 2022.
Glucagon Like Peptide 2 Receptor can be divided into FE-203799, Glepaglutide, GXG-8 and HM-15910, etc. FE-203799 is the mainstream product in the market, accounting for % sales share globally in 2022.
Glucagon Like Peptide 2 Receptor is widely used in various fields, such as Short Bowel Syndrome, Diabetes, Diarrhea and Obesity, etc. Short Bowel Syndrome provides greatest supports to the Glucagon Like Peptide 2 Receptor industry development. In 2022, global % sales of Glucagon Like Peptide 2 Receptor went into Short Bowel Syndrome filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Glucagon Like Peptide 2 Receptor market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Hanmi Pharmaceuticals Co Ltd
Naia Ltd
Takeda
Tasly Pharmaceutical Group Co Ltd
Zealand Pharma AS
Segment by Type
FE-203799
Glepaglutide
GXG-8
HM-15910
Others

Segment by Application


Short Bowel Syndrome
Diabetes
Diarrhea
Obesity
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Glucagon Like Peptide 2 Receptor market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Glucagon Like Peptide 2 Receptor, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Glucagon Like Peptide 2 Receptor industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Glucagon Like Peptide 2 Receptor in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Glucagon Like Peptide 2 Receptor introduction, etc. Glucagon Like Peptide 2 Receptor Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Glucagon Like Peptide 2 Receptor market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Glucagon Like Peptide 2 Receptor Market Overview
1.1 Glucagon Like Peptide 2 Receptor Product Overview
1.2 Glucagon Like Peptide 2 Receptor Market Segment by Type
1.2.1 FE-203799
1.2.2 Glepaglutide
1.2.3 GXG-8
1.2.4 HM-15910
1.2.5 Others
1.3 Global Glucagon Like Peptide 2 Receptor Market Size by Type
1.3.1 Global Glucagon Like Peptide 2 Receptor Market Size Overview by Type (2018-2034)
1.3.2 Global Glucagon Like Peptide 2 Receptor Historic Market Size Review by Type (2018-2024)
1.3.3 Global Glucagon Like Peptide 2 Receptor Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Glucagon Like Peptide 2 Receptor Sales Breakdown by Type (2018-2024)
1.4.2 Europe Glucagon Like Peptide 2 Receptor Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Glucagon Like Peptide 2 Receptor Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Breakdown by Type (2018-2024)
2 Global Glucagon Like Peptide 2 Receptor Market Competition by Company
2.1 Global Top Players by Glucagon Like Peptide 2 Receptor Sales (2018-2024)
2.2 Global Top Players by Glucagon Like Peptide 2 Receptor Revenue (2018-2024)
2.3 Global Top Players by Glucagon Like Peptide 2 Receptor Price (2018-2024)
2.4 Global Top Manufacturers Glucagon Like Peptide 2 Receptor Manufacturing Base Distribution, Sales Area, Product Type
2.5 Glucagon Like Peptide 2 Receptor Market Competitive Situation and Trends
2.5.1 Glucagon Like Peptide 2 Receptor Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Glucagon Like Peptide 2 Receptor Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucagon Like Peptide 2 Receptor as of 2022)
2.7 Date of Key Manufacturers Enter into Glucagon Like Peptide 2 Receptor Market
2.8 Key Manufacturers Glucagon Like Peptide 2 Receptor Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Glucagon Like Peptide 2 Receptor Status and Outlook by Region
3.1 Global Glucagon Like Peptide 2 Receptor Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Glucagon Like Peptide 2 Receptor Historic Market Size by Region
3.2.1 Global Glucagon Like Peptide 2 Receptor Sales in Volume by Region (2018-2024)
3.2.2 Global Glucagon Like Peptide 2 Receptor Sales in Value by Region (2018-2024)
3.2.3 Global Glucagon Like Peptide 2 Receptor Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Glucagon Like Peptide 2 Receptor Forecasted Market Size by Region
3.3.1 Global Glucagon Like Peptide 2 Receptor Sales in Volume by Region (2024-2034)
3.3.2 Global Glucagon Like Peptide 2 Receptor Sales in Value by Region (2024-2034)
3.3.3 Global Glucagon Like Peptide 2 Receptor Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Glucagon Like Peptide 2 Receptor by Application
4.1 Glucagon Like Peptide 2 Receptor Market Segment by Application
4.1.1 Short Bowel Syndrome
4.1.2 Diabetes
4.1.3 Diarrhea
4.1.4 Obesity
4.1.5 Others
4.2 Global Glucagon Like Peptide 2 Receptor Market Size by Application
4.2.1 Global Glucagon Like Peptide 2 Receptor Market Size Overview by Application (2018-2034)
4.2.2 Global Glucagon Like Peptide 2 Receptor Historic Market Size Review by Application (2018-2024)
4.2.3 Global Glucagon Like Peptide 2 Receptor Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Glucagon Like Peptide 2 Receptor Sales Breakdown by Application (2018-2024)
4.3.2 Europe Glucagon Like Peptide 2 Receptor Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Glucagon Like Peptide 2 Receptor Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Breakdown by Application (2018-2024)
5 North America Glucagon Like Peptide 2 Receptor by Country
5.1 North America Glucagon Like Peptide 2 Receptor Historic Market Size by Country
5.1.1 North America Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Glucagon Like Peptide 2 Receptor Sales in Volume by Country (2018-2024)
5.1.3 North America Glucagon Like Peptide 2 Receptor Sales in Value by Country (2018-2024)
5.2 North America Glucagon Like Peptide 2 Receptor Forecasted Market Size by Country
5.2.1 North America Glucagon Like Peptide 2 Receptor Sales in Volume by Country (2024-2034)
5.2.2 North America Glucagon Like Peptide 2 Receptor Sales in Value by Country (2024-2034)
6 Europe Glucagon Like Peptide 2 Receptor by Country
6.1 Europe Glucagon Like Peptide 2 Receptor Historic Market Size by Country
6.1.1 Europe Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Glucagon Like Peptide 2 Receptor Sales in Volume by Country (2018-2024)
6.1.3 Europe Glucagon Like Peptide 2 Receptor Sales in Value by Country (2018-2024)
6.2 Europe Glucagon Like Peptide 2 Receptor Forecasted Market Size by Country
6.2.1 Europe Glucagon Like Peptide 2 Receptor Sales in Volume by Country (2024-2034)
6.2.2 Europe Glucagon Like Peptide 2 Receptor Sales in Value by Country (2024-2034)
7 Asia-Pacific Glucagon Like Peptide 2 Receptor by Region
7.1 Asia-Pacific Glucagon Like Peptide 2 Receptor Historic Market Size by Region
7.1.1 Asia-Pacific Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Glucagon Like Peptide 2 Receptor Forecasted Market Size by Region
7.2.1 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Glucagon Like Peptide 2 Receptor Sales in Value by Region (2024-2034)
8 Latin America Glucagon Like Peptide 2 Receptor by Country
8.1 Latin America Glucagon Like Peptide 2 Receptor Historic Market Size by Country
8.1.1 Latin America Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Glucagon Like Peptide 2 Receptor Sales in Volume by Country (2018-2024)
8.1.3 Latin America Glucagon Like Peptide 2 Receptor Sales in Value by Country (2018-2024)
8.2 Latin America Glucagon Like Peptide 2 Receptor Forecasted Market Size by Country
8.2.1 Latin America Glucagon Like Peptide 2 Receptor Sales in Volume by Country (2024-2034)
8.2.2 Latin America Glucagon Like Peptide 2 Receptor Sales in Value by Country (2024-2034)
9 Middle East and Africa Glucagon Like Peptide 2 Receptor by Country
9.1 Middle East and Africa Glucagon Like Peptide 2 Receptor Historic Market Size by Country
9.1.1 Middle East and Africa Glucagon Like Peptide 2 Receptor Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Glucagon Like Peptide 2 Receptor Forecasted Market Size by Country
9.2.1 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Glucagon Like Peptide 2 Receptor Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Hanmi Pharmaceuticals Co Ltd
10.1.1 Hanmi Pharmaceuticals Co Ltd Company Information
10.1.2 Hanmi Pharmaceuticals Co Ltd Introduction and Business Overview
10.1.3 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Products Offered
10.1.5 Hanmi Pharmaceuticals Co Ltd Recent Development
10.2 Naia Ltd
10.2.1 Naia Ltd Company Information
10.2.2 Naia Ltd Introduction and Business Overview
10.2.3 Naia Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Naia Ltd Glucagon Like Peptide 2 Receptor Products Offered
10.2.5 Naia Ltd Recent Development
10.3 Takeda
10.3.1 Takeda Company Information
10.3.2 Takeda Introduction and Business Overview
10.3.3 Takeda Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Takeda Glucagon Like Peptide 2 Receptor Products Offered
10.3.5 Takeda Recent Development
10.4 Tasly Pharmaceutical Group Co Ltd
10.4.1 Tasly Pharmaceutical Group Co Ltd Company Information
10.4.2 Tasly Pharmaceutical Group Co Ltd Introduction and Business Overview
10.4.3 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Products Offered
10.4.5 Tasly Pharmaceutical Group Co Ltd Recent Development
10.5 Zealand Pharma AS
10.5.1 Zealand Pharma AS Company Information
10.5.2 Zealand Pharma AS Introduction and Business Overview
10.5.3 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Zealand Pharma AS Glucagon Like Peptide 2 Receptor Products Offered
10.5.5 Zealand Pharma AS Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Glucagon Like Peptide 2 Receptor Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Glucagon Like Peptide 2 Receptor Industrial Chain Analysis
11.4 Glucagon Like Peptide 2 Receptor Market Dynamics
11.4.1 Glucagon Like Peptide 2 Receptor Industry Trends
11.4.2 Glucagon Like Peptide 2 Receptor Market Drivers
11.4.3 Glucagon Like Peptide 2 Receptor Market Challenges
11.4.4 Glucagon Like Peptide 2 Receptor Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Glucagon Like Peptide 2 Receptor Distributors
12.3 Glucagon Like Peptide 2 Receptor Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of FE-203799
Table 2. Major Company of Glepaglutide
Table 3. Major Company of GXG-8
Table 4. Major Company of HM-15910
Table 5. Major Company of Others
Table 6. Global Glucagon Like Peptide 2 Receptor Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Glucagon Like Peptide 2 Receptor Sales by Type (2018-2024) & (K Pcs)
Table 8. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Glucagon Like Peptide 2 Receptor Sales by Type (2018-2024) & (US& Million)
Table 10. Global Glucagon Like Peptide 2 Receptor Market Share in Value by Type (2018-2024)
Table 11. Global Glucagon Like Peptide 2 Receptor Price by Type (2018-2024) & (USD/Pcs)
Table 12. Global Glucagon Like Peptide 2 Receptor Sales by Type (2024-2034) & (K Pcs)
Table 13. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Glucagon Like Peptide 2 Receptor Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Type (2024-2034)
Table 16. Global Glucagon Like Peptide 2 Receptor Price by Type (2024-2034) & (USD/Pcs)
Table 17. North America Glucagon Like Peptide 2 Receptor Sales by Type (2018-2024) & (K Pcs)
Table 18. North America Glucagon Like Peptide 2 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Type (2018-2024)
Table 20. Europe Glucagon Like Peptide 2 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Type (2018-2024)
Table 22. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Type (2018-2024)
Table 24. Latin America Glucagon Like Peptide 2 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales (K Pcs) by Type (2018-2024)
Table 26. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Glucagon Like Peptide 2 Receptor Sales by Company (2018-2024) & (K Pcs)
Table 28. Global Glucagon Like Peptide 2 Receptor Sales Share by Company (2018-2024)
Table 29. Global Glucagon Like Peptide 2 Receptor Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Glucagon Like Peptide 2 Receptor Revenue Share by Company (2018-2024)
Table 31. Global Market Glucagon Like Peptide 2 Receptor Price by Company (2018-2024) & (USD/Pcs)
Table 32. Global Glucagon Like Peptide 2 Receptor Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Glucagon Like Peptide 2 Receptor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucagon Like Peptide 2 Receptor as of 2022)
Table 35. Date of Key Manufacturers Enter into Glucagon Like Peptide 2 Receptor Market
Table 36. Key Manufacturers Glucagon Like Peptide 2 Receptor Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Glucagon Like Peptide 2 Receptor Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Glucagon Like Peptide 2 Receptor Sales by Region (2018-2024) & (K Pcs)
Table 40. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Glucagon Like Peptide 2 Receptor Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Region (2018-2024)
Table 43. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 44. Global Glucagon Like Peptide 2 Receptor Sales by Region (2024-2034) & (K Pcs)
Table 45. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Glucagon Like Peptide 2 Receptor Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Region (2024-2034)
Table 48. Global Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2024-2034)
Table 49. Global Glucagon Like Peptide 2 Receptor Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Glucagon Like Peptide 2 Receptor Sales by Application (2018-2024) & (K Pcs)
Table 51. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Glucagon Like Peptide 2 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Application (2018-2024)
Table 54. Global Glucagon Like Peptide 2 Receptor Price by Application (2018-2024) & (USD/Pcs)
Table 55. Global Glucagon Like Peptide 2 Receptor Sales by Application (2024-2034) & (K Pcs)
Table 56. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Glucagon Like Peptide 2 Receptor Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Application (2024-2034)
Table 59. Global Glucagon Like Peptide 2 Receptor Price by Application (2024-2034) & (USD/Pcs)
Table 60. North America Glucagon Like Peptide 2 Receptor Sales by Application (2018-2024) (K Pcs)
Table 61. North America Glucagon Like Peptide 2 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Glucagon Like Peptide 2 Receptor Sales by Application (2018-2024) (K Pcs)
Table 63. Europe Glucagon Like Peptide 2 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Application (2018-2024) (K Pcs)
Table 65. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Glucagon Like Peptide 2 Receptor Sales by Application (2018-2024) (K Pcs)
Table 67. Latin America Glucagon Like Peptide 2 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Application (2018-2024) (K Pcs)
Table 69. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Glucagon Like Peptide 2 Receptor Sales by Country (2018-2024) & (K Pcs)
Table 71. North America Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Glucagon Like Peptide 2 Receptor Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Country (2018-2024)
Table 74. North America Glucagon Like Peptide 2 Receptor Sales by Country (2024-2034) & (K Pcs)
Table 75. North America Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Glucagon Like Peptide 2 Receptor Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Glucagon Like Peptide 2 Receptor Sales by Country (2018-2024) & (K Pcs)
Table 79. Europe Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Glucagon Like Peptide 2 Receptor Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Glucagon Like Peptide 2 Receptor Sales by Country (2024-2034) & (K Pcs)
Table 83. Europe Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Glucagon Like Peptide 2 Receptor Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Region (2018-2024) & (K Pcs)
Table 87. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Region (2024-2034) & (K Pcs)
Table 91. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2018-2024) & (K Pcs)
Table 95. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2024-2034) & (K Pcs)
Table 99. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Glucagon Like Peptide 2 Receptor Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2018-2024) & (K Pcs)
Table 103. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2024-2034) & (K Pcs)
Table 107. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Country (2024-2034)
Table 110. Hanmi Pharmaceuticals Co Ltd Company Information
Table 111. Hanmi Pharmaceuticals Co Ltd Introduction and Business Overview
Table 112. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 113. Hanmi Pharmaceuticals Co Ltd Glucagon Like Peptide 2 Receptor Product
Table 114. Hanmi Pharmaceuticals Co Ltd Recent Development
Table 115. Naia Ltd Company Information
Table 116. Naia Ltd Introduction and Business Overview
Table 117. Naia Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 118. Naia Ltd Glucagon Like Peptide 2 Receptor Product
Table 119. Naia Ltd Recent Development
Table 120. Takeda Company Information
Table 121. Takeda Introduction and Business Overview
Table 122. Takeda Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 123. Takeda Glucagon Like Peptide 2 Receptor Product
Table 124. Takeda Recent Development
Table 125. Tasly Pharmaceutical Group Co Ltd Company Information
Table 126. Tasly Pharmaceutical Group Co Ltd Introduction and Business Overview
Table 127. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Tasly Pharmaceutical Group Co Ltd Glucagon Like Peptide 2 Receptor Product
Table 129. Tasly Pharmaceutical Group Co Ltd Recent Development
Table 130. Zealand Pharma AS Company Information
Table 131. Zealand Pharma AS Introduction and Business Overview
Table 132. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 133. Zealand Pharma AS Glucagon Like Peptide 2 Receptor Product
Table 134. Zealand Pharma AS Recent Development
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Glucagon Like Peptide 2 Receptor Market Trends
Table 138. Glucagon Like Peptide 2 Receptor Market Drivers
Table 139. Glucagon Like Peptide 2 Receptor Market Challenges
Table 140. Glucagon Like Peptide 2 Receptor Market Restraints
Table 141. Glucagon Like Peptide 2 Receptor Distributors List
Table 142. Glucagon Like Peptide 2 Receptor Downstream Customers
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Glucagon Like Peptide 2 Receptor Product Picture
Figure 2. Global Glucagon Like Peptide 2 Receptor Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Glucagon Like Peptide 2 Receptor Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Glucagon Like Peptide 2 Receptor Sales Status and Outlook (2018-2034) & (K Pcs)
Figure 5. Product Picture of FE-203799
Figure 6. Global FE-203799 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 7. Product Picture of Glepaglutide
Figure 8. Global Glepaglutide Sales YoY Growth (2018-2034) & (K Pcs)
Figure 9. Product Picture of GXG-8
Figure 10. Global GXG-8 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 11. Product Picture of HM-15910
Figure 12. Global HM-15910 Sales YoY Growth (2018-2034) & (K Pcs)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 15. Global Glucagon Like Peptide 2 Receptor Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Type in 2022 & 2034
Figure 17. North America Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Type in 2022
Figure 18. North America Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Type in 2022
Figure 19. Europe Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Type in 2022
Figure 20. Europe Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Type in 2022
Figure 23. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Glucagon Like Peptide 2 Receptor Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Glucagon Like Peptide 2 Receptor Revenue in 2022
Figure 29. Glucagon Like Peptide 2 Receptor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Short Bowel Syndrome
Figure 31. Global Short Bowel Syndrome Sales YoY Growth (2018-2034) & (K Pcs)
Figure 32. Product Picture of Diabetes
Figure 33. Global Diabetes Sales YoY Growth (2018-2034) & (K Pcs)
Figure 34. Product Picture of Diarrhea
Figure 35. Global Diarrhea Sales YoY Growth (2018-2034) & (K Pcs)
Figure 36. Product Picture of Obesity
Figure 37. Global Obesity Sales YoY Growth (2018-2034) & (K Pcs)
Figure 38. Product Picture of Others
Figure 39. Global Others Sales YoY Growth (2018-2034) & (K Pcs)
Figure 40. Global Glucagon Like Peptide 2 Receptor Sales by Application (2018-2034) & (US$ Million)
Figure 41. Global Glucagon Like Peptide 2 Receptor Sales Market Share by Application in 2022 & 2034
Figure 42. North America Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Application in 2022
Figure 43. North America Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Application in 2022
Figure 44. Europe Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Application in 2022
Figure 45. Europe Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Application in 2022
Figure 46. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Application in 2022
Figure 47. Asia-Pacific Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Application in 2022
Figure 48. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share in Volume by Application in 2022
Figure 49. Latin America Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Application in 2022
Figure 50. Middle East and Africa Glucagon Like Peptide 2 Receptor Sales Market Share in Value by Application in 2022
Figure 51. Key Raw Materials Price
Figure 52. Glucagon Like Peptide 2 Receptor Manufacturing Cost Structure
Figure 53. Glucagon Like Peptide 2 Receptor Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries